Alzheimer's enzyme important for myelin

Beta-secretase enzyme involved in Alzheimer's pathology is required for peripheral nerve myelination

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
An enzyme involved in Alzheimer's disease also contributes to myelination of peripheral nerves, according to a study in this week in Science. Inhibitors of this enzyme, called beta-Secretase, are considered to be prime candidates for Alzheimer's treatment, so the enzyme's role in myelination may have implications for potential side effects of these drugs, the authors say."It's a mild cautionary note to those who are developing the beta-secretase drugs," said Robert Vassar of Northwestern University in Evanston, Ill., who was not involved in the study.In Alzheimer's disease, amyloid beta (Aß) peptide accumulates in the brain. A beta-secretase enzyme called BACE1 (ß-site APP cleaving enzyme-1) is required for Aß synthesis; in BACE knockout mice, no Aß peptide is produced .Although BACE1's role in Alzheimer's is fairly well-established, not much is known about the enzyme's possible role in normal physiology, said study senior author Christian Haass of Ludwig-Maximilians-University in Münich. Led by Michael Willem, also of Ludwig-Maximilians-University, the researchers found that BACE1 expression is highest in postnatal mice when neurons are becoming coated in myelin. The researchers also found that the pattern of BACE1 expression in the peripheral nervous system is very similar to that of neuregulin 1, a factor uknown to be important for myelination.Using electron microscopy, the researchers found that the myelin surrounding the peripheral nerves in BACE1 knockouts is abnormally thin. They also found that unprocessed neuregulin 1 accumulates in BACE1 knockout animals, indicating that BACE1 is likely required for neuregulin 1 to myelinate axons normally.Based on these results, "BACE clearly plays a very important role in development, particularly in controlling the myelin sheath thickness," said Philip Wong of Johns Hopkins University in Baltimore, who was not involved in the study. The finding "came as a big surprise to all of us," Haass told The Scientist in an email.Since Aß peptides cannot be synthesized in the absence of beta-secretase activity, many researchers are hopeful that inhibitors of beta-secretases may be effective in treating Alzheimer's disease. Beta-secretase inhibitors blocking nerve myelination should not be a problem in adult patients, Wong said, as long as BACE1 is not responsible for maintenance of the myelin sheath. It's possible that a problem could arise if a patient taking beta-secretase inhibitors for Alzheimer's disease sustained a peripheral nerve injury, Vassar said. Based on the study's findings, the drugs might prevent injured nerves from repairing myelin. "It's something to be aware of" when beta-secretase inhibitors are tested in clinical trials, Vassar said, "but I don't think it's a big red flag." Melissa Lee Phillips
mphillips@the-scientist.comLinks within this articleD. Steinberg, "Testing Potential Alzheimer Vaccines," The Scientist, January 21, 2002. http://www.sciencemag.orgE. Russo, "The Search for Secretases," The Scientist, November 8, 1999. http://www.the-scientist.com/1999/11/08/7/1J.B. Weitzman, "Mining myelination," The Scientist, June 27, 2002. 'http://www.the-scientist.com/article/display/20487Robert Vassar http://www.cmb.northwestern.edu/faculty/robert_vassar.htmH. Cai et al., "BACE1 is the major beta-secretase for generation of Abeta peptides by neurons," Nature Neuroscience, March 2001. http://www.the-scientist.com/pubmed/11056475Christian Haass http://haass.web.med.uni-muenchen.deMichael Willem http://haass.web.med.uni-muenchen.de/willem.htmlA.N. Garratt et al., "Neuregulin, a factor with many functions in the life of a schwann cell," Bioessays, November 2000. http://www.the-scientist.com/pubmed/11056475Philip Wong http://www.hopkinsmedicine.org/graduateprograms/cmm/wong.htmlR. Vassar et al., "The beta-secretase, BACE: a prime drug target for Alzheimer's disease," Journal of Molecular Neuroscience, October 2001. http://www.the-scientist.com/pubmed/11816789
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Melissa Lee Phillips

    This person does not yet have a bio.
Share
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
Unraveling Complex Biology with Advanced Multiomics Technology

Unraveling Complex Biology with Five-Dimensional Multiomics

Element Bioscience Logo
Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Twist Bio 
The Scientist Placeholder Image

Seeing and Sorting with Confidence

BD
The Scientist Placeholder Image

Streamlining Microbial Quality Control Testing

MicroQuant™ by ATCC logo

Products

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies

waters-logo

How Alderley Analytical are Delivering eXtreme Robustness in Bioanalysis